These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31677953)

  • 1. ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example.
    Emborg HD; Kahlert J; Braeye T; Bauwens J; Bollaerts K; Danieli G; Duarte-Salles T; Glismann S; Huerta-Alvarez C; de Lusignan S; Martín-Merino E; McGee C; Correa A; Tramontan L; Weibel D; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B22-B30. PubMed ID: 31677953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination.
    Tin Tin Htar M; de Ridder M; Braeye T; Correa A; McGee C; de Lusignan S; Duarte-Salles T; Huerta-Alvarez C; Martín-Merino E; Tramontan L; Danieli G; Picelli G; van der Maas N; Berencsi K; Arnheim-Dahlström L; Heininger U; Emborg HD; Weibel D; Bollaerts K; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B31-B37. PubMed ID: 31677949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.
    Weibel D; Dodd C; Mahaux O; Haguinet F; De Smedt T; Duarte-Salles T; Picelli G; Tramontan L; Danieli G; Correa A; McGee C; Martín-Merino E; Huerta-Alvarez C; Berencsi K; Emborg HD; Bollaerts K; Bauchau V; Titievsky L; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B38-B46. PubMed ID: 31677946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.
    Braeye T; Emborg HD; Llorente-García A; Huerta C; Martín-Merino E; Duarte-Salles T; Danieli G; Tramontan L; Weibel D; McGee C; Villa M; Gini R; Lehtinen M; Titievsky L; Sturkenboom M
    Vaccine; 2020 Apr; 38(16):3243-3254. PubMed ID: 32171573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations.
    Sturkenboom M; Braeye T; van der Aa L; Danieli G; Dodd C; Duarte-Salles T; Emborg HD; Gheorghe M; Kahlert J; Gini R; Huerta-Alvarez C; Martín-Merino E; McGee C; de Lusignan S; Picelli G; Roberto G; Tramontan L; Villa M; Weibel D; Titievsky L
    Vaccine; 2020 Dec; 38 Suppl 2():B8-B21. PubMed ID: 32061385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.
    Bollaerts K; Ledent E; de Smedt T; Weibel D; Emborg HD; Danieli G; Duarte-Salles T; Huerta-Alvarez C; Martín-Merino E; Picelli G; Tramontan L; Sturkenboom M; Bauchau V
    Vaccine; 2020 Dec; 38 Suppl 2():B65-B75. PubMed ID: 31677947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.
    Gini R; Dodd CN; Bollaerts K; Bartolini C; Roberto G; Huerta-Alvarez C; Martín-Merino E; Duarte-Salles T; Picelli G; Tramontan L; Danieli G; Correa A; McGee C; Becker BFH; Switzer C; Gandhi-Banga S; Bauwens J; van der Maas NAT; Spiteri G; Sdona E; Weibel D; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B56-B64. PubMed ID: 31677950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.
    Bollaerts K; de Smedt T; McGee C; Emborg HD; Villa M; Alexandridou M; Duarte-Salles T; Gini R; Bartolini C; de Lusignan S; Tin Tin Htar M; Titievsky L; Sturkenboom M; Bauchau V
    Vaccine; 2020 Dec; 38 Suppl 2():B76-B83. PubMed ID: 31677951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data.
    Dodd C; de Ridder M; Weibel D; Mahaux O; Haguinet F; de Smedt T; de Lusignan S; McGee C; Duarte-Salles T; Emborg HD; Huerta-Alvarez C; Martín-Merino E; Picelli G; Berencsi K; Danieli G; Sturkenboom M
    Vaccine; 2020 Dec; 38 Suppl 2():B47-B55. PubMed ID: 32280043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.
    Braeye T; Bauchau V; Sturkenboom M; Emborg HD; García AL; Huerta C; Merino EM; Bollaerts K
    PLoS One; 2019; 14(9):e0222296. PubMed ID: 31532806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
    Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
    Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort Study.
    Pérez Chacón G; Fathima P; Jones M; Estcourt MJ; Gidding HF; Moore HC; Richmond PC; Snelling T
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):670-680. PubMed ID: 38182097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An economic evaluation of universal pertussis vaccination in Italy.
    Beutels P; Bonanni P; Tormans G; Canale F; Crovari PC
    Vaccine; 1999 May; 17(19):2400-9. PubMed ID: 10392622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological estimation of the effectiveness of the pertussis vaccination during outbreaks in a community. Les pédiatres et bactériologistes du réseau RENACOQ].
    Baron S; Grimprel E; Daurat G; Cuisinet C; Ponge A; Haeghebaert S; Guiso N; Desenclos JC; Drucker J
    Arch Pediatr; 1997 Aug; 4(8):744-50. PubMed ID: 9337897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for Pertussis Immunisation and Food Allergy (PIFA): a case-control study of the association between pertussis vaccination in infancy and the risk of IgE-mediated food allergy among Australian children.
    Estcourt MJ; Marsh JA; Campbell DE; Gold MS; Allen KJ; Richmond P; Waddington CS; Snelling TL
    BMJ Open; 2018 Jan; 8(1):e020232. PubMed ID: 29391374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whooping cough, twenty years from acellular vaccines introduction.
    Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
    Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of pertussis in two Ibero-American countries with different vaccination policies: lessons derived from different surveillance systems.
    Solano R; Masa-Calles J; Garib Z; Grullón P; Santiago SL; Brache A; Domínguez Á; Caylà JA
    BMC Public Health; 2016 Nov; 16(1):1178. PubMed ID: 27876021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which strategy for pertussis vaccination today?
    Girard DZ
    Paediatr Drugs; 2002; 4(5):299-313. PubMed ID: 11994035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.